Molnupiravir by Merck

Molnupiravir

Merck Sharp and Dohme (MSD) developed molnupiravir in collaboration with Ridgeback Biotherapeutics. "Molnupiravir is the oral prodrug of beta-D-N4-hydroxycytidine (NHC), a ribonucleoside that has shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials. NHC uptake by viral RNA-dependent…
Digital surveillance

Digital ID – surveillance

Digital surveillance will help usher in a China-style "social credit system" for the entire world. The technologies are available now that will start being used on your phone, and migrate to under your skin, maybe even within your body (nanotechnology)…
Adverse Events - news, reports, analysis

Post-jab AE Topics

Adverse Events following COVID-19 injections is a big topic. I am re-organising pages to make content easier to publish and locate. This page will capture the reverse-chronological order format of videos and articles relating to general breaking news and data…